Top compounds associated with response to CCNO

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:tretinoin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.062	0.09
mRNA	Tipifarnib	GDSC1000	pan-cancer	AAC	0.06	0.1
mRNA	Bortezomib	gCSI	pan-cancer	AAC	0.12	0.1
mRNA	AT7867	CTRPv2	pan-cancer	AAC	0.06	0.1
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.062	0.1
mRNA	JQ-1:MK-0752 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.058	0.1
mRNA	Vorinostat	GDSC1000	pan-cancer	AAC	-0.052	0.1
mRNA	Gemcitabine	GDSC1000	pan-cancer	AAC	0.058	0.1
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.059	0.1
mRNA	THZ-2-102-1	GDSC1000	pan-cancer	AAC	-0.05	0.1

Download CSV